Cardiac autonomic function is preserved in young adults with major depressive disorder

Ashley M Darling1, Cynthia M Dominguez2, Rachel J Skow1,3

  • 1Department of Kinesiology, The University of Texas at Arlington, Arlington, Texas, United States.

Insights

Major depressive disorder (MDD) in young adults does not appear to impair cardiac autonomic function, including heart rate variability and baroreflex sensitivity. Depressive symptom severity also showed no link to autonomic dysfunction in this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Autonomic Neuroscience

Background:

  • Major depressive disorder (MDD) is prevalent in young adults and linked to increased cardiovascular disease (CVD) risk.
  • Mechanisms underlying this association, particularly cardiac autonomic function, are not well understood.
  • Previous studies on young adults with MDD have yielded inconsistent findings regarding cardiac autonomic function.

Purpose of the Study:

  • To investigate heart rate variability (HRV) and cardiac baroreflex sensitivity (BRS) in young, unmedicated adults with MDD compared to healthy adults.
  • To examine the relationship between depressive symptom severity and cardiac autonomic function in young adults with MDD.

Main Methods:

  • Continuous recording of heart rate and beat-to-beat blood pressure during supine rest.
  • Assessment of HRV (RMSSD) and cardiac BRS (overall gain) in 37 unmedicated adults with mild-to-moderate MDD and 28 healthy adults (HA).
  • Statistical analysis to compare HRV and BRS between groups and correlate with symptom severity.

Main Results:

  • No significant differences were found in HRV (RMSSD: 79±36 ms vs. 63±34 ms) or cardiac BRS (overall gain: 23±7 ms/mmHg vs. 21±10 ms/mmHg) between young adults with MDD and HA.
  • No association was observed between current depressive symptom severity and HRV (R²=0.004) or cardiac BRS (R²=0.02) in the MDD group.
  • These findings suggest preserved cardiac autonomic function in young, unmedicated adults with mild-to-moderate MDD.

Conclusions:

  • Cardiac autonomic function, specifically HRV and BRS, appears to be preserved in young, unmedicated adults with mild-to-moderate MDD.
  • The elevated CVD risk in young adults with MDD may not be directly attributable to cardiac autonomic dysfunction.
  • Further research is needed to explore other potential mechanisms linking MDD to cardiovascular risk in this demographic.

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
247
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237